Author(s): Walsh JJ, Pesik N, Quinn CP, Urdaneta V, Dykewicz CA, , Walsh JJ, Pesik N, Quinn CP, Urdaneta V, Dykewicz CA,
Abstract Share this page
Abstract This report describes the first case of naturally acquired inhalation anthrax in the United States since 1976. The patient's clinical course included adjunctive treatment with human anthrax immunoglobulin. Clinical correlation of serologic assays for the lethal factor component of lethal toxin and anti-protective antigen immunoglobulin G are also presented.
This article was published in Clin Infect Dis
and referenced in Medical Safety & Global Health